Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZQK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,273
Award facts
- Contract value 100% obligated
- $19,273.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pens with a contract ceiling value of $19,273.27 and ultimate completion date of January 13, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal healthcare requirements across military treatment facilities and defense medical supply chains.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs through its comprehensive IDC vehicle with DLA. The company supplies a broad portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs globally. This delivery order for Wegovy, a diabetes and weight management medication, represents a routine fulfillment under the broader pharmaceutical prime vendor agreement designed to ensure reliable access to essential medications for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4ZQK?
SPE2DR26F4ZQK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4ZQK worth?
The government has obligated $19,273 on SPE2DR26F4ZQK.
Is contract SPE2DR26F4ZQK an order under another contract?
Yes. SPE2DR26F4ZQK is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZQK competed?
The extent of competition for SPE2DR26F4ZQK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award